pradigastat   Click here for help

GtoPdb Ligand ID: 7830

Synonyms: LCQ-908 | LCQ908
Compound class: Synthetic organic
Comment: Pradigastat is a potent and selective inhibitor of diacylglycerol O-acyltransferase 1 (DGAT1).
The PubChem CID 53387035 shows the molecule with no stereochemistry.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 75.11
Molecular weight 455.18
XLogP 5.75
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)CC1CCC(CC1)c1ccc(cc1)c1ccc(cn1)Nc1ccc(nc1)C(F)(F)F
Isomeric SMILES OC(=O)C[C@@H]1CC[C@H](CC1)c1ccc(cc1)c1ccc(cn1)Nc1ccc(nc1)C(F)(F)F
InChI InChI=1S/C25H24F3N3O2/c26-25(27,28)23-12-10-21(15-30-23)31-20-9-11-22(29-14-20)19-7-5-18(6-8-19)17-3-1-16(2-4-17)13-24(32)33/h5-12,14-17,31H,1-4,13H2,(H,32,33)/t16-,17-
InChI Key GXALXAKNHIROPE-QAQDUYKDSA-N
References
1. Meyers C, Gaudet D, Tremblay K, Amer A, Chen J, Aimin F. (2012)
The DGAT1 inhibitor LCQ908 decreases triglyceride levels in patients with the familial chylomicronemia syndrome.
Journal of Clinical Lipidology, 6: 266-267.
2. Novartis. 
CLCQ908 Type 2 Diabetes Mellitus (T2DM).
Accessed on 29/10/2014. Modified on 29/10/2014. Novartis Clinical Trial Results Database, http://www.novctrd.com/ctrdWebApp/clinicaltrialrepository/public/product.jsp?divisionId=2&productID=417&diseaseAreaID=5